MedPath

Lescol

These highlights do not include all the information needed to use Lescol / Lescol XL safely and effectively. See full prescribing information for Lescol / Lescol XL. Lescol (fluvastatin sodium) capsules/ Lescol XL (fluvastatin sodium) extended-release tablets for oral use Initial U.S. Approval: 1993/ 2000

Approved
Approval ID

cd12fae6-f277-4679-a7a8-b98719fe6fa9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 31, 2012

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

fluvastatin sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-4471
Application NumberNDA021192
Product Classification
M
Marketing Category
C73594
G
Generic Name
fluvastatin sodium
Product Specifications
Route of AdministrationORAL
Effective DateMarch 1, 2012
FDA Product Classification

INGREDIENTS (10)

HYPROMELLOSE 2208 (15000 MPA.S)Inactive
Code: Z78RG6M2N2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FLUVASTATIN SODIUMActive
Quantity: 80 mg in 1 1
Code: PYF7O1FV7F
Classification: ACTIM
HYDROXYPROPYL CELLULOSE (TYPE H)Inactive
Code: RFW2ET671P
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
POTASSIUM BICARBONATEInactive
Code: HM5Z15LEBN
Classification: IACT
POVIDONESInactive
Code: FZ989GH94E
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lescol - FDA Drug Approval Details